Post-Trade Analysis: Chemours Company (CC) Slides -3.52, Closing at 23.01

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $23.85 in the prior trading day, Chemours Company (NYSE: CC) closed at $23.01, down -3.52%. In other words, the price has decreased by -$3.52 from its previous closing price. On the day, 1.88 million shares were traded. CC stock price reached its highest trading level at $24.15 during the session, while it also had its lowest trading level at $22.97.

Ratios:

Our goal is to gain a better understanding of CC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 856.55. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 5.66 whereas as Long-Term Debt/Eq ratio is at 5.54.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on June 07, 2024, initiated with a Neutral rating and assigned the stock a target price of $25.

On April 09, 2024, BMO Capital Markets Upgraded its rating to Outperform which previously was Underperform and also upped its target price recommendation from $19 to $34.

UBS Downgraded its Buy to Neutral on March 05, 2024, whereas the target price for the stock was revised from $37 to $21.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CC now has a Market Capitalization of 3551156480 and an Enterprise Value of 6942081536. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.59 while its Price-to-Book (P/B) ratio in mrq is 4.55. Its current Enterprise Value per Revenue stands at 1.189 whereas that against EBITDA is 7.989.

Stock Price History:

The Beta on a monthly basis for CC is 1.79, which has changed by -0.312724 over the last 52 weeks, in comparison to a change of 0.2586832 over the same period for the S&P500. Over the past 52 weeks, CC has reached a high of $39.05, while it has fallen to a 52-week low of $15.10. The 50-Day Moving Average of the stock is -13.01%, while the 200-Day Moving Average is calculated to be -17.19%.

Shares Statistics:

The stock has traded on average 1.39M shares per day over the past 3-months and 1585120 shares per day over the last 10 days, according to various share statistics. A total of 148.59M shares are outstanding, with a floating share count of 147.03M. Insiders hold about 1.25% of the company’s shares, while institutions hold 76.86% stake in the company. Shares short for CC as of 1715731200 were 5872598 with a Short Ratio of 3.85, compared to 1713139200 on 5344575. Therefore, it implies a Short% of Shares Outstanding of 5872598 and a Short% of Float of 5.89.

Dividends & Splits

In the trailing 12 months, CC’s forward annual dividend rate was 1.0, compared to 1.00 this year. Against a Trailing Annual Dividend Yield of 0.04192872The stock’s 5-year Average Dividend Yield is 4.24.

Most Popular